Colitis: all 1,059 studies

Page 11 of 11. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.

• Treatment With Local PPARgamma Ligand in Distal Ulcerative ColitisStatus unknownNCT00309660Phase 1/2
• Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)TerminatedNCT00307827Phase 2
• Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile ColitisCompletedNCT00304889
• Fecal Bacterial Flora in Clostridium Difficile-Associated DiarrheaCompletedNCT00304876
• Addition of Lactobacillus to Metronidazole in Treatment of CDADWithdrawnNCT00304863Phase 4
• Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin AntibodyCompletedNCT00304408
• Response of Clostridium Difficile Infection to Metronidazole TherapyCompletedNCT00304369
• Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative ColitisCompletedNCT00303381Phase 2
• Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative ColitisCompletedNCT00299013Phase 3
• A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative ColitisCompletedNCT00295282Phase 1
• NBI With Magnification for Dysplasia Detection in Ulcerative ColitisStatus unknownNCT00292175Not applicable
• Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab StudyTerminatedNCT00279435Phase 2/3
• A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative ColitisTerminatedNCT00279422Phase 2/3
• Chromoendoscopy for Ulcerative Colitis SurveillanceCompletedNCT00274209
• Study to Identify Non-Invasive Markers of Gastrointestinal AllergyCompletedNCT00272818
• New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative ColitisCompletedNCT00269438Phase 3
• Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative ColitisTerminatedNCT00268164Phase 2
• Data Bank for Eosinophilic DisordersCompletedNCT00267475
• Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative ColitisCompletedNCT00267306Phase 1/2
• Rituximab in Active Ulcerative ColitisCompletedNCT00261118Phase 2/3
• Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.WithdrawnNCT00259571Phase 2/3
• Dose Finding Study for Retarded Phosphatidylcholine in PancolitisCompletedNCT00259558Phase 2
• Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative ColitisCompletedNCT00259545Phase 2
• A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.TerminatedNCT00254618Phase 1
• Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety StudyCompletedNCT00232258Phase 2
• Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel DiseaseCompletedNCT00222378
• Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205)CompletedNCT00219414Phase 4
• Cerebral Resonance Magnetic Imaging During Rectal DistentionWithdrawnNCT00213330
• Pentasa Once Daily in Ulcerative Colitis for Maintenance of RemissionCompletedNCT00209300Phase 3
• Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative ColitisTerminatedNCT00209287Phase 4
• A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis PatientsCompletedNCT00207688
• Asacol Dosing Study for Active Ulcerative ColitisCompletedNCT00194818Phase 4
• Treatment of Microscopic ColitisTerminatedNCT00184171Not applicable
• Budesonide for Maintenance Treatment of Collagenous ColitisCompletedNCT00180076Phase 3
• Budesonide Treatment for Lymphocytic ColitisCompletedNCT00180050Phase 3
• The Influence of 5-Aminosalicylates on Thiopurine Metabolite LevelsCompletedNCT00167882Phase 4
• Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative ColitisTerminatedNCT00152841Phase 2
• Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.CompletedNCT00151944Phase 3
• Wireless Capsule Endoscopy in Ulcerative ColitisCompletedNCT00145808Phase 3
• Long-Term Treatment of Collagenous Colitis With BudesonideStatus unknownNCT00139165Phase 3
• A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCompletedNCT00106509Phase 3
• Study for the Treatment of Ulcerative Colitis With AdacolumnCompletedNCT00102193Phase 3
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative ColitisCompletedNCT00096655Phase 3
• CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) RemissionCompletedNCT00092508Phase 3
• Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative ColitisCompletedNCT00073047Phase 2
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's DiseaseCompletedNCT00072943Phase 2
• FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064454Phase 3
• FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative ColitisCompletedNCT00064441Phase 3
• ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis.CompletedNCT00063830Phase 2
• ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative ColitisCompletedNCT00063414Phase 2
• Clotrimazole Enemas for Pouchitis in Children and AdultsTerminatedNCT00061282Phase 1/2
• Study Evaluating rhIL-11 in Left-Sided Ulcerative ColitisTerminatedNCT00038922Phase 1
• A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative ColitisCompletedNCT00036439Phase 3
• A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated DiarrheaCompletedNCT00034294Phase 2
• Safety and Efficacy of OP2000 (Deligoparin) in the Treatment of Active Ulcerative ColitisCompletedNCT00033943Phase 2/3
• Research Study in Patients With Severe Ulcerative ColitisCompletedNCT00032305Phase 2/3
• Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative ColitisCompletedNCT00004810Phase 2
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDSCompletedNCT00002273Not applicable
• A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS PatientsCompletedNCT00000768Phase 1

← Colitis overview